CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics Meeting Abstract


Authors: Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; Zamarin, D.; Solit, D. B.; Schultz, N.; Abida, W.
Abstract Title: CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
Meeting Title: 111th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 80
Issue: 16 Suppl.
Meeting Dates: 2020 Apr 27-28/Jun 22-24
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-08-01
Language: English
ACCESSION: WOS:000590059303448
DOI: 10.1158/1538-7445.Am2020-1308
PROVIDER: wos
Notes: Meeting Abstract: 1308 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    583 Morris
  2. David Solit
    781 Solit
  3. Dmitriy Zamarin
    202 Zamarin
  4. Anuradha Gopalan
    418 Gopalan
  5. Dana Elizabeth Rathkopf
    275 Rathkopf
  6. Howard Scher
    1130 Scher
  7. Wassim Abida
    158 Abida
  8. Nikolaus D Schultz
    491 Schultz
  9. Emily Steinberger Weg
    12 Weg
  10. Philip Wayne Kantoff
    198 Kantoff
  11. Bastien Nguyen
    31 Nguyen
  12. Jose Mauricio Mota
    13 Mota